InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.33
(
0.36%
)
Bitcoin
63,061.52
(
-0.15%
)

Replies to post #314165 on Avid Bioservices Inc (CDMO)

Replies to #314165 on Avid Bioservices Inc (CDMO)

patientlywaiting

10/16/17 6:26 AM

#314166 RE: hutschi #314165

"By standardizing and validating biomarkers for immunotherapy while also developing and exploring new biomarkers, we hope to advance rapidly toward a new future of precision oncology that benefits all patients," Collins told the briefing."